Techniques for transperineal delivery of a denervating agent to the prostate gland

a technology of denervating agent and prostate gland, which is applied in the field of prostate treatment, can solve the problems of pain and trauma, the delivery of ablation energy can be traumatic and painful for some patients, and the ablation technique may be difficult to perform for some patients, so as to achieve precise delivery of denervating agent, less trauma to patients, and convenient to perform by physicians

Inactive Publication Date: 2005-05-05
MEDTRONIC INC
View PDF23 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0014] In comparison to known implementations of prostate ablation, various embodiments of the present invention may provide one or more advantages. In particular, the invention provides alternatives to an ablation procedure for treatment of BPH or other prostate disorders which may be easier to perform by a physician and/or less traumatic to the patient.
[0015] Moreover, in comparison to known techniques for delivery of neurotoxins, the invention can provide significant improvements. For example, the invention can allow for more precise delivery of a denervating agen

Problems solved by technology

The problems include, for example, pain and trauma associated with some existing transurethral ablation techniques.
Delivery of ablatio

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Techniques for transperineal delivery of a denervating agent to the prostate gland
  • Techniques for transperineal delivery of a denervating agent to the prostate gland
  • Techniques for transperineal delivery of a denervating agent to the prostate gland

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] Delivery of a denervating agent, such as botulinum toxin, to a patient's prostate gland has shown significant promise as a therapy for treating benign prostatic hyperplasia (BPH) or other prostate disorders. For this reason, techniques and devices that enable the delivery of a denervating agent to a patient's prostate gland are highly desirable. This disclosure describes three different techniques for delivery of a denervating agent to the prostate gland: a transurethral technique, a transperineal technique and a transrectal technique. Various devices and systems are also described for use with the respective techniques, or the like.

[0031]FIG. 1 is a schematic diagram illustrating a device 10 for transurethral delivery of a denervating agent to the prostate gland of a patient. As shown in FIG. 1, device 10 includes a handle 14, a barrel 16, and a transurethral shaft 20 extending from barrel 16. Device 10 also includes a denervating agent delivery assembly 19, which can be vi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention is directed to a technique for delivering a denervating agent to a patient's prostate gland. In particular, the invention is directed to a transperineal technique for delivering the denervating agent. Devices and systems are also described for use in implementing the technique.

Description

FIELD OF THE INVENTION [0001] The invention relates generally to prostate treatment and, more particularly, to techniques for a delivering an agent to the prostate gland. BACKGROUND [0002] Benign prostatic hyperplasia (BPH) is one of the most common medical problems experienced by men over 50 years old. Urinary tract obstruction due to prostatic hyperplasia has been recognized since the earliest days of medicine. Hyperplastic enlargement of the prostate gland often leads to compression of the urethra, resulting in obstruction of the urinary tract and the subsequent development of symptoms including frequent urination, decrease in urinary flow, nocturia, pain, discomfort, and dribbling. [0003] One common surgical procedure used for treating BPH is transurethral needle ablation (TUNA). The TUNA technique involves transurethral delivery of an electrically conductive ablation needle to the prostate site. The electrically conductive ablation needle penetrates the prostate gland in a dire...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61B17/00A61M25/00
CPCA61B2017/00274A61M25/0084A61B2018/00547
Inventor GERBER, MARTIN T.SWOYER, JOHN M.
Owner MEDTRONIC INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products